Exosomes from human adipose-derived stem cells promote sciatic nerve regeneration via optimizing Schwann cell...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Neuroscience

Background:

• Peripheral nerve injury poses significant challenges in treatment and recovery.
• Stem cell-derived exosomes are emerging as potent mediators of therapeutic effects.
• Human adipose-derived stem cells (ASCs) offer a promising source for therapeutic exosomes.

Purpose of the Study:

• To investigate the therapeutic potential of human ASC-derived exosomes (ASC-Exos) in peripheral nerve regeneration.
• To elucidate the mechanisms by which ASC-Exos influence Schwann cell function.
• To evaluate the efficacy of ASC-Exo therapy in an in vivo model of peripheral nerve injury.

Main Methods:

• In vitro studies assessing Schwann cell proliferation, migration, myelination, and neurotrophic factor secretion upon ASC-Exos internalization.
• In vivo evaluation using a rat sciatic nerve transection model with a 10-mm gap.
• Assessment of axon regeneration, myelination, and muscle atrophy recovery in ASC-Exos treated rats.

Main Results:

• ASC-Exos significantly promoted Schwann cell proliferation, migration, and myelination in vitro by upregulating key genes.
• ASC-Exos enhanced the secretion of neurotrophic factors from Schwann cells.
• In vivo, ASC-Exos treatment led to significantly improved axon regeneration, myelination, and restoration of muscle function compared to controls.

Conclusions:

• Human ASC-derived exosomes effectively promote peripheral nerve regeneration by optimizing Schwann cell function.
• ASC-Exos represent a novel and promising therapeutic strategy for nerve tissue engineering.
• This study highlights the potential of exosome-based therapies in regenerative medicine for peripheral nerve injuries.